Asia Pacific Metagenomics Market Size & Outlook, 2024-2030
- Biotechnology
- Genomics & Genetic Engineering
- Metagenomics Market Outlook
- Genomics & Genetic Engineering
Global Market
Related Markets
Ask Prism AI about the metagenomics market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
Asia Pacific metagenomics market highlights
- The Asia Pacific metagenomics market generated a revenue of USD 374.6 million in 2023.
- The market is expected to grow at a CAGR of 14% from 2024 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product in 2023.
- Sequencing & Data Analytics Services is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 374.6 million |
| Market revenue in 2030 | USD 938.3 million |
| Growth rate | 14% (CAGR from 2023 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Sequencing & Data Analytics Services |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits & Reagents, Sequencing & Data Analytics Services, Software |
| Key market players worldwide | Bio-Rad Laboratories Inc, Illumina Inc, PerkinElmer, Thermo Fisher Scientific Inc, Novogene, Promega, Qiagen NV, Takara Bio Inc, Oxford Nanopore Technologies PLC, Roche Holding AG |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 18.5% of the global metagenomics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 938.3 million by 2030.
Healthcare and clinical research service providers in Japan have been integrating Next-Generation Sequencing (NGS) technologies for the past couple of years. They are expected to account for a considerable share of Asia Pacific metagenomics revenue share.
Ongoing developments in HLA and prenatal NGS testing, coupled with international collaborations with U.S. & European companies, are expected to fuel the growth of Japan metagenomics market during the forecast period. Moreover, many hospitals in Japan have started using NGS-based mutational profile screening for patients with solid tumors to direct patients to relevant clinical trials.
Various cancer gene panels to be used in clinical practice have also been approved by the Ministry of Health, Labour and Welfare of Japan. However, a medical protocol for reporting and interpreting clinical variants must be developed. Using sequencing technology in this field, significant progress has been made in understanding the molecular causes of cancer.
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Metagenomics Market Scope
Metagenomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Roche Holding AG | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Takara Bio Inc | View profile | 1,793 | Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058 | www.takara-bio.co.jp |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | www.perkinelmer.com |
| Novogene | View profile | 501-1000 | Beijing, Beijing, China, Asia | en.novogene.com/ |
| Promega | View profile | 5001-10000 | Madison, Wisconsin, United States, North America | www.promega.com/es |
| Oxford Nanopore Technologies PLC | View profile | 1,133 | Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, United Kingdom, OX4 4DQ | www.nanoporetech.com |
Asia Pacific Metagenomics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Metagenomics Market Outlook will help companies and investors design strategic landscapes.
Kits & Reagents was the largest segment with a revenue share of 61.45% in 2023.
Horizon Databook has segmented the Asia Pacific metagenomics market based on kits & reagents, sequencing & data analytics services, software covering the revenue growth of each sub-segment from 2018 to 2030.
Healthcare and clinical research service providers in Japan have been integrating Next-Generation Sequencing (NGS) technologies for the past couple of years. They are expected to account for a considerable share of Asia Pacific metagenomics revenue share.
Ongoing developments in HLA and prenatal NGS testing, coupled with international collaborations with U.S. & European companies, are expected to fuel the growth of Japan metagenomics market during the forecast period. Moreover, many hospitals in Japan have started using NGS-based mutational profile screening for patients with solid tumors to direct patients to relevant clinical trials.
Various cancer gene panels to be used in clinical practice have also been approved by the Ministry of Health, Labour and Welfare of Japan. However, a medical protocol for reporting and interpreting clinical variants must be developed. Using sequencing technology in this field, significant progress has been made in understanding the molecular causes of cancer.
- Asia Pacific Metagenomics Market Application Outlook (Revenue, USD Million , 2018-2030)
- Others
- Clinical Diagnostics
- Drug Discovery
- Biotechnology
- Environmental
- Food & nutrition
- Asia Pacific Metagenomics Market Technology Outlook (Revenue, USD Million , 2018-2030)
- Whole Genome Sequencing
- Shotgun Sequencing
- Others
- 16S Sequencing
- Asia Pacific Metagenomics Market Product Outlook (Revenue, USD Million , 2018-2030)
- Sequencing & Data Analytics Services
- Kits & Reagents
- Software
- Asia Pacific Metagenomics Market Workflow Outlook (Revenue, USD Million , 2018-2030)
- Pre-sequencing
- Sequencing
- Data Analysis
Reasons to subscribe to Metagenomics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Metagenomics Market Outlook databook
- Our clientele includes a mix of Metagenomics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific Metagenomics Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific Metagenomics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Asia Pacific Metagenomics Market, 2018-2030 (US$M)
Asia Pacific metagenomics market statistics, by application, 2018-2030 (US$M)
